Public-registry site landscape for NCT05079126, a Interstitial Lung Disease study sponsored by Diffusion Pharmaceuticals Inc. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05079126 (registry record) |
| Sponsor | Diffusion Pharmaceuticals Inc |
| Condition(s) | Interstitial Lung Disease |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05079126 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →